Psychiatry & Neurology, Sleep Medicine · Sugar Land, TX
NPI
1295975324
Since 2009
Specialty
Psychiatry & Neurology, Sleep Medicine
Code 2084S0012X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2245 Texas Dr Ste 300
Sugar Land, TX, 77479
Phone (281) 566-2621
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
760 services
Medicare patients, 2024
179
Average age 72
Drug cost, 2024
$1.1M
624 prescriptions
Company payments, 2025
$242K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerard J Meskill was code 99457 (e&m - miscellaneous), 342 times for 49 patients. In total Gerard J Meskill billed 760 services in 12 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99457 E&M - Miscellaneous | Office | 342 | 49 | $36.63 | $13K |
| 99214 Office E&M - Established | Office | 191 | 121 | $76.04 | $15K |
| 95800 Sleep Study | Office | 128 | 62 | $101.62 | $13K |
| 99205 Office E&M - New | Office | 42 | 42 | $147.95 | $6,214 |
| 99215 Office E&M - Established | Office | 23 | 17 | $122.36 | $2,814 |
| 95810 Sleep Study | Office | 12 | 12 | $88.78 | $1,065 |
By year: 2022 $38K for 379 services; 2023 $41K for 432 services; 2024 $51K for 760 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gerard J Meskill prescribed most often to Medicare patients was Zolpidem Tartrate, with 83 prescriptions and refills. In total Gerard J Meskill wrote 624 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zolpidem Tartrate Generic | 83 | 99 | 13 | $2,344 |
| Zaleplon Generic | 71 | 91 | 18 | $1,685 |
| Xywav Sodium,calcium,mag,pot Oxybate | 67 | 67 | Under 11 | $855K |
| Armodafinil Generic | 43 | 55 | Under 11 | $2,226 |
| Clonazepam Generic | 36 | 36 | Under 11 | $145 |
| Sunosi Solriamfetol Hcl | 25 | 31 | Under 11 | $26K |
| Belsomra Suvorexant | 20 | 25 | Under 11 | $10K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 17 | 43 | Under 11 | $266 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 16 | 16 | Under 11 | $650 |
| Methylphenidate Hcl Generic | 15 | 15 | Under 11 | $204 |
| Eszopiclone Generic | 13 | 23 | Under 11 | $503 |
| Temazepam Generic | 12 | 12 | Under 11 | $228 |
| Quviviq Daridorexant Hcl | 12 | 12 | Under 11 | $5,953 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 11 | 11 | Under 11 | $1,951 |
| Wakix Pitolisant Hcl | 11 | 11 | Under 11 | $148K |
Brand drugs: 165 claims; generic drugs: 459 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerard J Meskill $242K ($242K in general payments such as food, travel and fees) from 8 companies. The largest payer was Lilly USA, LLC with $93K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.